Phase I/II clinical trial of combination of OX40 and HDAC inhibitor in patients with Stage IV NSCLC Read more
The Effects And Mechanisms Of TNF-α/TNFR2 In Regulatory T Cells On Microenvironment And Progression In Gastric Cancer Read more
?A Phase 1/2, Dose Escalation And Expansion Study Of The Safety, Tolerability, And Anti-Tumor Activity Of BND-22 Administered Alone And In Combination With Pembrolizumab Or With Cetuximab In Patients With Advanced Solid Tumors Read more
A Phase 1, Multicenter, Open-Label Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Preliminary Efficacy Of TAB006, As Monotherapy And In Combination With Toripalimab, In Patients With Previously Treated, Advanced Malignancies Read more
Phase I Study Dose Finding Study To Evaluate Safety, Reactogenicity And Immunogenicity Of CV09040102 RAS G12D Mrna Vaccine In HLA- Selected Patients With Pancreatic Cancer Or Colorectal Cancer Harboring The RAS G12D Mutation Read more
Dose Escalation In Patients With Advanced Solid Tumors, And Expansion In Selected Indications Read more
An Open-Label, Multicenter, Dose-Escalation, Phase I Study To Evaluate Safety, Pharmacokinetics, And Preliminary Anti-Tumor Activity Of Ro7444973 In Participants With Advanced And/Or Metastatic Mage A4-Positive, Solid Tumors. Read more
A Phase 1a/1b Study Exploring the Safety and Tolerability of INCB081776 in Participants With Advanced Malignancies Read more
